Skip to main content

Ovid Therapeutics Inc.

OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636651

No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Ovid Therapeutics Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of OVID: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders7582+7
Shares46.3M47.6M+1.24M (+2.7%)
Value$54.7M$44.4M−$10.3M (−18.8%)

New holders (14)

Institutions that held Ovid Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to OVID in Q4 2024
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.1,000,000$933.7K0.00%
Sio Capital Management, LLC1,000,000$933.7K0.26%
Jacobs Levy Equity Management, Inc291,701$272.4K0.00%
Monimus Capital Management, LP138,266$129.1K0.12%
Velan Capital Investment Management LP70,000$65.4K0.06%
Susquehanna International Group, LLP45,120$42.1K0.00%
Intech Investment Management LLC23,724$22.2K0.00%
AQR Capital Management LLC10,639$9.93K0.00%
Citadel Advisors LLC7,457$6.96K0.00%
Capital Advisors, Ltd. LLC1,710$2.00K0.00%
The PNC Financial Services Group, Inc.261$2440.00%
SBI Securities Co., Ltd.84$780.00%
EverSource Wealth Advisors, LLC21$200.00%
IFP Advisors, Inc8$70.00%

Sold out (7)

Institutions that held Ovid Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of OVID in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Prosight Management, LP729,208$860.5K
XTX Topco Ltd38,230$45.1K
Tejara Capital Ltd29,329$34.6K
China Universal Asset Management Co., Ltd.13,650$16.1K
Connor, Clark & Lunn Investment Management Ltd.11,431$13.5K
Mirae Asset Global Investments Co., Ltd.2,567$3.03K
Capital Performance Advisors LLP146$172